Vaxart Granted Extension by Nasdaq to Regain Compliance
August 29, 2025 08:00 ET Â | Source: Vaxart, Inc. - Company must…
Ancora Issues Letter to CSXs Board of Directors Regarding the Need to Avert a Permanent Impairment of Value and Aggressively Pursue a Value-Maximizing Merger
Asserts the Board Should Immediately Announce the Formal Retention of an Investment…
IOC reaffirms commitment to advancing sustainable development through sport at the local level
25 July 2025 -Â Building on its ongoing efforts to support sustainable development…
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
July 11, 2025 16:30 ET Â | Source: Ultragenyx Pharmaceutical Inc. Complete Response…
Prime Success Responds to Sinovac Biotechs False and Misleading Claims
For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its…
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
June 02, 2025 19:30 ET Â | Source: Semilux International Ltd. Taipei, Taiwan,…